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Poster Session I S267Discussion: The above results suggest that inhibition of NFATc2
signaling in CD34+ HSC using CSA results in more rapid differen-
tiation towards the myelomonocytic and erythroid lineage (as seen
by flow cytometry) without affecting cell proliferation. These results
need to be further validated by RNAi mediated NFATc2 knock out
in HSC’s in vitro. These studies will lead to better understanding of
regulation of HSC differentiation and may have implications for
routine CSA administration in patients undergoing allogeneic
transplantation.
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EVALUATION OF TRANSPLANT CENTER UNRELATED DONOR SEARCH
STRATEGY PROFICIENCY
Malmberg, C.L., Davis, J., Beduhn, E., Buck, K., Chitphakdithai, P.,
Hermanson, J., Kempenich, J., Maus, T., Olson, K., Tram, K.,
Wood, J. National Marrow Donor Program, Minneapolis, MN
The National Marrow Donor Program (NMDP) evaluated the
proficiency ofU.S. transplant centers (TC) in selecting unrelated do-
nors (URD) for hematopoietic cell transplantation. The study iden-
tifies TC specific and individual search specific factors that influence
the likelihood of the best matched donors being selected for further
typing.We also evaluated changes in search proficiency since a com-
parable study in 2005.
Methods: Up to five random new patient searches of the Be
The Match Registry were evaluated for each TC from June –
September 2011; 25% accrued less than five. All searches were eval-
uated by HLA experts for three search proficiency characteristics:
patient HLA typing (loci/resolution), search strategy approach (se-
lect best potential HLA match), and number of donors selected for
further typing - each were given a score from 0-3. A total score
was calculated per search and stratified into high (perfect) and low
(not perfect) proficiency groups. Five factors were evaluated for cor-
relation to proficiency: use of NMDP search services - Search Strat-
egy Advice or Custom Search Support (CSS), presence of Certified
Hematopoietic Transplant Coordinator (CHTC) staff, URD pro-
curements (FY 2010), and difficult search (Yes/No).
Results: 566 patient searches from 130 TCs were included in the
current study; 76% rated in the high proficiency group and 24% in
the low. Univariate andmultivariate analysis concurred that searches
which received CSS, were performed at TCs with CHTC staff, or
were not difficult were more likely to have a high proficiency rating
(Table 1). Searches that received CSS were more than four times as
likely to have the highest proficiency rating. Similarly, searches at
TCs that had CHTC staff were about two times as likely to be high
proficiency while searches that were not difficult were about 1.5
times as likely. The majority of searches in the low proficiency group
did not select an adequate number of donors.
Conclusions: U.S. TCs have improved their search proficiency
from 52% in the high proficiency group in 2005 to 76% in 2011.
During this time, NMDP initiatives which may have influenced
TC proficiency include publications (NMDP matching guidelines),
a new search service (CSS), HapLogic predictions and donor list
sorting, and network education. The most frequent characteristic
of searches in the low proficiency group was selecting an inadequate
number of donors for extended typing which can delay a search.
Table 1. Logistic Regression Results for Search Proficiency
Rating
FavorableFactor N OR (95% CI) p-value characteristicProcurement Level 0.073 Not significantLow 81 1.00Medium 350 1.89 (0.84-4.25) 0.127(Continued )Table 1. (Continued)Factor N OR (95% CI) p-valueFavorable
characteristicHigh 135 1.05 (0.45-2.46) 0.907CSS sent to TC
before formalCSS sent to TC
before formalYes 71 4.13 (1.39-12.28) 0.011No 495 1.00SSA sent to TC
before formalNot significantYes 32 1.13 (0.47-2.74) 0.781No 534 1.00At least 1 CHTC
on staffHad at least
1 CHTC staffYes 239 2.07 (1.22-3.50) 0.007No 327 1.00Difficult search Not difficultYes 226 0.63 (0.42-0.93) 0.020No 340 1.00OR indicates odds ratio; CI indicates confidence interval173
EXPANSION OF T-CELLS FROM THE CORD BLOOD GRAFT AS A PREDIC-
TIVE TOOL FOR COMPLICATIONS AND OUTCOME OF CORD BLOOD
TRANSPLANTATION
Gertow, J.1, Berglund, S.1, Okas, M.1, K€arre, K.2, Remberger, M.1,
Mattsson, J.1, Uhlin, M.1 1Karolinska University Hospital Huddinge,
Stockholm, Sweden; 2Karolinska Institutet, Stockholm, Sweden
We have previously successfully expanded functional T-cells in
vitro from cord blood grafts used for clinical transplantation,
with the aim of creating donor lymphocyte infusions to treat e.g.
malignant relapse. Here we show that the T cell expansion in ad-
dition might work as a prognostic tool for in vivo complications af-
ter transplantation. We used multi-color flow cytometry to
correlate in vitro phenotypical data from 33 expansions to the clin-
ical outcome post-transplantation. Higher levels of CD69+ acti-
vated T-cells in the expansion were associated with prolonged
survival of the patient. In addition, we found a correlation between
T-cell expansions containing relatively high levels of effector mem-
ory T-cells and transplant-related complications. Our data suggest
that expansions of cord blood T-cells from the graft might not only
be used as donor lymphocyte infusions, but also as in vitro indica-
tors that could give essential information on how to manage cord
blood transplanted patients.174
EFFECTIVENESS OF UNRELATED DONOR ALLOGENEIC HEMATOPOIETIC
CELL TRANSPLANTATION: RESULTS OF A DONOR VS. NO DONOR
ANALYSIS
Pidala, J., Kim, J., Schell, M., Hillgruber, R., Nye, V., Ayala, E.,
Alsina, M., Betts, B., Bookout, R., Fernandez, H.F., Field, T.,
Locke, F.L., Nishihori, T., Ochoa, J.L., Perez, L., Perkins, J.,
Shapiro, J., Tate, C., Tomblyn, M., Anasetti, C. Moffitt Cancer Center,
Tampa, FL
In a consecutive series of unrelated donor searches conducted
fromMarch, 2006 through December, 2009 at Moffitt Cancer Cen-
ter, we studied the following: (1) likelihood of finding a suitable (7-
8/8) high-resolution matched unrelated donor; (2) factors associated
with reaching transplant (HCT) among those with a donor; and (3)
the effect of unrelated donor vs. no donor status on survival by in-
tention to treat (ITT) analysis. Those with a fully HLA-A, -B, -C,
and –DRB1 (8/8) matched or single locus (7/8) mismatched unre-
lated donor were defined as donor (n 5 448), while those without
were no donor (n 5 83). Median time from search initiation to do-
nor identification was 21 days; 95% of these values were within 59
